From our vantage point, many biotech and biopharma firms struggling with talent attraction and retention have three commonalities. Discover what they are—but more importantly—what you can do.
Read MoreCHROs and other relative roles such as CPOs deserve a spot on your Board – particularly given the immense focus on talent attraction and retention currently.
Read MorePsychedelics have explosive potential in the mental health space, but strong market optimism is balanced by institutional wariness – and even bias.
Read MoreNvidia’s new Hopper 100 GPU represents a massive, industry-changing leap forward for drug discovery powered by machine learning.
Read MoreAre Special Purpose Acquisition Companies (SPACs) here to stay? Paul Cashman shares his thoughts plus when to use them.
Read MoreMore than ever, companies are having to adapt quickly to attract and retain talent. One area is age-inclusive leadership. Learn more!
Read MoreJennifer Phillips provides a comprehensive breakdown of a potential cancer vaccine, and the role biotech has in its development.
Read MoreLearn more about the science behind human motivation and how this can provide a roadmap for managers in driving meaningful employee engagement.
Read MoreThe future of drug discovery is among the most exciting – and fastest-growing – domains for the use of artificial intelligence (AI). See three reasons why!
Read MoreThis is the first of several articles covering the history, current state, and projected future of psychedelics research in biotech.
Read More